Osteoarthritis, Knee Clinical Trial
— INSPIREOfficial title:
Molecular Signatures of Endocannabinoid Induced Pain Relief in Humans: Lifestyle Interventions, Systemic and Localised Changes
NCT number | NCT05670314 |
Other study ID # | 473-0322 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2022 |
Est. completion date | November 1, 2024 |
This pilot study will be a placebo controlled randomised intervention study in which participants with knee pain will be grouped into the diet intervention, exercise intervention, diet and exercise intervention or placebo arm. The study involves intake of dietary supplements and performing routine exercises which are commonly used and are not pharmacological agents. The end-points of the study are non-clinical outcomes. N= 120. 2x2 intervention with 30 individuals per block: placebo, diet only, exercise only, diet + exercise
Status | Recruiting |
Enrollment | 120 |
Est. completion date | November 1, 2024 |
Est. primary completion date | November 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - Participant is willing and able to give informed consent for participation in the study - Participant eligibility includes those aged >18 years who have a body mass index (BMI) between 18.5 and 39.9 kg/m2 Exclusion Criteria: The participant may not enter the study if ANY of the following apply: - Have psychosocial or gastrointestinal (e.g. malabsorptive conditions such as IBS/IBD, coeliac) - Are taking the following medications: immunosuppressants, anticoagulants, amiodarone and/or perhexiline - Are currently following or anticipated to commence a specialised commercially available weight loss diet and/or program - Pregnant or breast feeding - History or current psychiatric illness - History or current neurological condition (e.g. epilepsy) - Those undergoing revision, having severe hip OA, inflammatory arthropathies - Diagnosed non-OA cause of knee pain (e.g. rheumatoid arthritis) - Neuropathy or diabetes mellitus - Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (this must remain for ALL UoN FMHS UREC approved studies) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Nottingham | Nottingham | Nottinghamshire |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Numerical Rate Score (NRS) for pain | The Numerical Rate Score (NRS) will be used to assess the changes in the level of pain in response to the intervention between baseline and follow-up. | Baseline and 6 weeks | |
Secondary | Changes in serum Endocannabinoid levels | Serum levels of Endocannabinoids will be measured using mass spectrometry in samples collected at baseline and at follow-up (at the end of six weeks). This will help us ascertain the change in levels of Endocannabinoids in response to the intervention. | Baseline and 6 weeks | |
Secondary | Changes in serum Cytokines levels | Serum levels of cytokines will be measured using ELISA in samples collected at baseline and at follow-up (at the end of six weeks). This will help us ascertain the change in levels of pro and anti-inflammatory cytokines in response to the intervention. | Baseline and 6 weeks | |
Secondary | Changes in serum markers of immune phenotyping (PBMCs) | Serum levels of PBMCs will be measured using a multiplex technique in samples collected at baseline and at follow-up (at the end of six weeks). This will help us ascertain the change in immunological function in response to the intervention. | Baseline and 6 weeks | |
Secondary | Changes in gut microbiome composition and short chain fatty acids | Changes in gut microbiome composition and serum levels of short-chain fatty acids (SCFAs) in response to the interventions. Gut microbiome composition will be measured using 16S sequencing on stool samples. SCFAs in serum will be measured using mass spectrometry. | Baseline and 6 weeks | |
Secondary | Changes in DNA methylation on a subset of individuals | DNA methylation will be measured using specialized ELISA kits in samples collected at baseline and at follow-up (at the end of six weeks). | Baseline and 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Terminated |
NCT02615522 -
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
|
||
Not yet recruiting |
NCT02854176 -
Somatosensory Stimulation in Knee Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT02865174 -
Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
|
Phase 4 |